2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride

C15H30ClN5O2 — CID 119448567

IUPAC2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride
SMILESCl.O=C(CNC(=O)NC1CCCCC1)NCCN1CCNCC1
InChIInChI=1S/C15H29N5O2.ClH/c21-14(17-8-11-20-9-6-16-7-10-20)12-18-15(22)19-13-4-2-1-3-5-13;/h13,16H,1-12H2,(H,17,21)(H2,18,19,22);1H
InChIKeyGWDVSUADZCPTAJ-UHFFFAOYSA-N
MW347.89 g/mol
LogP0.06
Rot. Bonds6

About 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride

2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride (PubChem CID 119448567) has the molecular formula C15H30ClN5O2 and a molecular weight of 347.89 g/mol. Its IUPAC name is 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride.

Molecular Properties

Compound Name2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride
PubChem CID119448567
Molecular FormulaC15H30ClN5O2
Molecular Weight347.89 g/mol
Exact Mass347.21
IUPAC Name2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride
SMILESCl.O=C(CNC(=O)NC1CCCCC1)NCCN1CCNCC1
InChIInChI=1S/C15H29N5O2.ClH/c21-14(17-8-11-20-9-6-16-7-10-20)12-18-15(22)19-13-4-2-1-3-5-13;/h13,16H,1-12H2,(H,17,21)(H2,18,19,22);1H
InChIKeyGWDVSUADZCPTAJ-UHFFFAOYSA-N
XLogP0.06
TPSA85.50 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500347.89
LogP ≤ 50.06
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Analyze 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-cyclohexyl-3-(2-piperazin-1-ylethyl)urea
CID 4056008
1-cyclobutyl-3-(2-pyrrolidin-1-ylethyl)urea
CID 115617971
N-cyclohexyl-3-piperazin-1-ylpropanamide
CID 28807752
N-cyclohexyl-3-(1,4-diazepan-1-yl)propanamide
CID 43162430
2-cyclohexyl-N-[2-oxo-2-(3-piperazin-1-ylpropylamino)ethyl]acetamide;hydrochloride
CID 119391449
2-acetamido-N-(2-piperazin-1-ylethyl)acetamide
CID 43600274
1-cycloheptyl-3-(2-morpholin-4-ylethyl)urea
CID 47163906
N-cyclohexyl-2-(cyclopentylcarbamoylamino)acetamide
CID 84516190
N-(2-piperazin-1-ylethyl)cyclooctanecarboxamide
CID 65019297
1-cyclohexyl-3-[1-(3-oxo-3-piperazin-1-ylpropyl)piperidin-4-yl]urea;hydrochloride
CID 120981215
1-cyclohexyl-3-(5-piperidin-1-ylpentyl)urea
CID 110446919
1-[2-(cyclohexylamino)-2-oxoethyl]-N-(2-piperazin-1-ylethyl)pyrazole-4-carboxamide;hydrochloride
CID 119447622

Frequently Asked Questions

What is the IUPAC name of 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride?
The IUPAC name of 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride (CID 119448567) is 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride.
What is the SMILES notation for 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride?
The canonical SMILES for 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride is Cl.O=C(CNC(=O)NC1CCCCC1)NCCN1CCNCC1.
What is the InChIKey of 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride?
The InChIKey is GWDVSUADZCPTAJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H29N5O2.ClH/c21-14(17-8-11-20-9-6-16-7-10-20)12-18-15(22)19-13-4-2-1-3-5-13;/h13,16H,1-12H2,(H,17,21)(H2,18,19,22);1H.
What are the key properties of 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride?
2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride has a molecular weight of 347.89 g/mol, XLogP of 0.06, 6 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(cyclohexylcarbamoylamino)-N-(2-piperazin-1-ylethyl)acetamide;hydrochloride is sourced from PubChem (CID 119448567), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).